Goiter persistence after iodine replenishment, the potential role of selenium deficiency in goitrous schoolchildren of Semirom, Iran.

BACKGROUND: Despite long-standing iodine supplementation in Iran, the prevalence of goiter remains high in some areas. This suggests other nutritional deficiencies may be considered as responsible factors of goiter persistence. Therefore, we assessed the prevalence of selenium deficiency in children living in a mountainous area in Iran to evaluate its correlation with goiter. METHODS: In this cross-sectional study, 1828 students from the 108 primary schools of urban and rural areas of Semirom in central Iran were selected by multistage random cluster sampling. After obtaining written consent from their parents, the children were examined for goiter grading. Grade 2 goitrous children (108 cases) were compared with non-goitrous children (111 children) as control group for serum selenium concentration. RESULTS: Overall, 36.7% of 1828 students had goiter. The mean and median urinary iodine excretion level was 19.3 and 18.5 mug/dl respectively. This was within normal limits. Of 219 evaluated cases, 109 children had selenium deficiency. Mean serum levels of selenium in the goitrous and control groups were 62.7 mug/l and 60.8 mug/l, respectively (p=0.42). There was a borderline significant difference of the goiter prevalence in selenium deficient and selenium sufficient subjects (40.8% vs. 54.3%, p=0.037). Twelve children had clinical or subclinical hypothyroidism. The mean (SD) serum selenium concentration of euthyroid and hypothyroid students were 61.9 (17.2) mug/l and 66.4 (11.9) mug/l respectively (p=0.35). CONCLUSION: In the area studied, selenium deficiency cannot explain high prevalence of goiter and other responsible factors should be investigated. Selenium deficiency may also have mild borderline significant protective effects on thyroid function and goiter.

Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study.

The aim of the present study was to investigate the potential antihypertensive effects of extracts of the flavonoid-rich Iranian flower, Crataegus curvisepala Lind., a member of the Rosaceae family. The hydroalcoholic extract of the leaves and flowers were studied in a double-blind, placebo-controlled clinical trial to determine its effects. A total of 92 men and women with primary mild hypertension, aged 40-60 years, were selected and divided randomly into two groups, receiving either hydroalcoholic extract of C. curvisepala Lind. or placebo three times daily for more than 4 months. Blood pressure (BP) was measured each month. Statistical analysis was carried out using Student's t-test. The results obtained showed a significant decrease in both systolic and diastolic BP after 3 months (p < 0.05). C. curvisepala has a time-dependent antihypertensive effect.